Soligenix, Inc. (SNGX)
0.3681
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
0.3681
0.00 (0.00%)
After-Hours: 20:00
Soligenix Debt to Equity Ratio : 0.0455 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0455 |
| March 31, 2026 | 0.107 |
| December 31, 2025 | 0.0677 |
| September 30, 2025 | 0.0507 |
| June 30, 2025 | 0.2249 |
| March 31, 2025 | 0.0219 |
| December 31, 2024 | 0.3605 |
| September 30, 2024 | 0.3712 |
| June 30, 2024 | 0.8428 |
| March 31, 2024 | 4.165 |
| December 31, 2023 | 1.385 |
| September 30, 2023 | 0.753 |
| June 30, 2023 | 0.5402 |
| March 31, 2023 | -2.723 |
| December 31, 2022 | -4.144 |
| September 30, 2022 | 9.938 |
| June 30, 2022 | 2.442 |
| March 31, 2022 | 1.510 |
| December 31, 2021 | 0.9291 |
| September 30, 2021 | 0.6631 |
| June 30, 2021 | 0.6414 |
| March 31, 2021 | 0.6029 |
| December 31, 2020 | 2.808 |
| September 30, 2020 | 0.0916 |
| June 30, 2020 | 0.0787 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0263 |
| December 31, 2019 | 0.0873 |
| September 30, 2019 | 0.0601 |
| June 30, 2019 | 0.0532 |
| March 31, 2019 | 0.0036 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.2847 |
| December 31, 2015 | -15.99 |
| September 30, 2015 | -0.6143 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.50M |
| Total Liabilities (Quarterly) | 3.854M |
| Shareholders Equity (Quarterly) | 6.646M |
| Current Ratio | 2.769 |
| Net Debt Paydown Yield | -0.52% |